Bonify Selects RavenQuest to Provide Management Services
GlobeNewswireDecember 21, 2018, 2:27 PM EST
VANCOUVER, British Columbia, Dec. 21, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB, OTCQB: RVVQF, Frankfurt: 1IT) announces it has been retained by Canadian Licensed Producer, Bonify. RavenQuest will provide comprehensive management services including operational direction and oversight to Bonify’s 320,000 square foot cannabis production facility located in Winnipeg, Manitoba.
RavenQuest has a lengthy history as a leading consultant in the Canadian cannabis space and has been retained for the purposes of maintaining compliance with Health Canada regulations and improving and streamlining production operations.
Bonify Chairman, Jeffery Dyck, stated that “Bonify’s board has complete confidence in RavenQuest’s ability to implement industry best standards of operation and production. We take organization culture very seriously and have selected, in RavenQuest, the industry leader in cannabis operational expertise so that Bonify can emerge as a top level producer as we move forward.”
SCROLL TO CONTINUE WITH CONTENTAd
Ready to meet someone new?
About RavenQuest BioMed Inc.
RavenQuest BioMed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development. RavenQuest is a licensed producer with facilities located in Markham, Ontario and Edmonton, Alberta. RavenQuest maintains a research partnership with Montreal’s McGill University focused upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant. The Company focuses on partnerships with Indigenous communities.
On Behalf of the Board of Directors of
RAVENQUEST BIOMED INC.
“George Robinson”
Chief Executive Officer
Story continues
Start the conversation
What to Read Next
Hemp is now legal in the U.S., so what does that mean for pot companies?
MarketWatch
Samsung Galaxy S9 and S9+
Samsung
Sponsored
A few things to remember about CBD oil before you spend money on it
MarketWatch
South Africa poised for cannabis trade despite obstacles
Associated Press
Despite hemp legalization, FDA will still consider CBD products largely illegal
MarketWatch
Motley Fool CEO's Rare "Double Down" Buy Alert
The Motley Fool
Sponsored
Judge blocks restrictions on who can apply for asylum
Associated Press
With Its 4.6% Dividend Yield, ExxonMobil Ranks Fourth
Market Realist
Stocks Finish Lower, Dow Tumbles 600+ Points
Yahoo Finance Video
Here's What Dental Implants Should Cost Today
Enlightened Economics
Sponsored
S&P 500 enters bear market
Yahoo Finance
Fed Raises Rates, Trims Forecast for Hikes in 2019 to Two
Bloomberg
Fed hikes rates, but signals just two more hikes in 2019
Yahoo Finance
New Car Prices Might Blow Your Mind
Zagline
Sponsored
Stocks tumble after Fed raises rates
Yahoo Finance
2 Keys to Alibaba’s Future Revenue Growth
Motley Fool
Kanye West gifted Kim Kardashian hundreds of thousands of dollars worth of stocks in 2017
Yahoo Finance Video
Did you know about these celeb couples - We Didn't
NinjaJournalist
Sponsored
